<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9252839</article-id>
    <article-id pub-id-type="pmid">35524567</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac318</article-id>
    <article-id pub-id-type="publisher-id">gkac318</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title><monospace>TADeus2</monospace>: a web server facilitating the clinical diagnosis by pathogenicity assessment of structural variations disarranging 3D chromatin structure</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9558-6504</contrib-id>
        <name>
          <surname>Poszewiecka</surname>
          <given-names>Barbara</given-names>
        </name>
        <!--b.poszewiecka@mimuw.edu.pl-->
        <aff><institution>Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw</institution>, 2 Banacha street, 02-097 Warsaw, <country country="PL">Poland</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1383-8019</contrib-id>
        <name>
          <surname>Pienkowski</surname>
          <given-names>Victor Murcia</given-names>
        </name>
        <aff><institution>Aix Marseille Univ, INSERM, Marseille Medical Genetics</institution>, MMG, Marseille, <country country="FR">France</country></aff>
        <aff><institution>Department of Medical Genetics, Medical University of Warsaw</institution>, Adolfa Pawińskiego 3c, 02-106 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6000-9387</contrib-id>
        <name>
          <surname>Nowosad</surname>
          <given-names>Karol</given-names>
        </name>
        <aff><institution>Department of Cell Biology, Erasmus Medical Center</institution>, Doctor Molewaterplein 40, 3015 GD Rotterdam, <country country="NL">Netherlands</country></aff>
        <aff><institution>Department of Biomedical Sciences, Laboratory of Molecular Genetics, Medical University of Lublin</institution>, Doktora Witolda Chodźki 1, 20-400 Lublin, <country country="PL">Poland</country></aff>
        <aff><institution>The Postgraduate School of Molecular Medicine, Medical University of Warsaw</institution>, Żwirki i Wigury 61, 02-091 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5865-8372</contrib-id>
        <name>
          <surname>Robin</surname>
          <given-names>Jérôme D</given-names>
        </name>
        <aff><institution>Aix Marseille Univ, INSERM, Marseille Medical Genetics</institution>, MMG, Marseille, <country country="FR">France</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5523-5198</contrib-id>
        <name>
          <surname>Gogolewski</surname>
          <given-names>Krzysztof</given-names>
        </name>
        <aff><institution>Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw</institution>, 2 Banacha street, 02-097 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3476-3017</contrib-id>
        <name>
          <surname>Gambin</surname>
          <given-names>Anna</given-names>
        </name>
        <!--aniag@mimuw.edu.pl-->
        <aff><institution>Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw</institution>, 2 Banacha street, 02-097 Warsaw, <country country="PL">Poland</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +48 225544521; Fax: +48 225544200; Email: <email>aniag@mimuw.edu.pl</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Barbara Poszewiecka. Email: <email>b.poszewiecka@mimuw.edu.pl</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-05-07">
      <day>07</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <volume>50</volume>
    <issue>W1</issue>
    <fpage>W744</fpage>
    <lpage>W752</lpage>
    <history>
      <date date-type="accepted">
        <day>21</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>12</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>12</day>
        <month>3</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac318.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>In recent years great progress has been made in identification of structural variants (SV) in the human genome. However, the interpretation of SVs, especially located in non-coding DNA, remains challenging. One of the reasons stems in the lack of tools exclusively designed for clinical SVs evaluation acknowledging the 3D chromatin architecture. Therefore, we present <monospace>TADeus2</monospace> a web server dedicated for a quick investigation of chromatin conformation changes, providing a visual framework for the interpretation of SVs affecting topologically associating domains (TADs). This tool provides a convenient visual inspection of SVs, both in a continuous genome view as well as from a rearrangement’s breakpoint perspective. Additionally, <monospace>TADeus2</monospace> allows the user to assess the influence of analyzed SVs within flaking coding/non-coding regions based on the Hi-C matrix. Importantly, the SVs pathogenicity is quantified and ranked using TADA, ClassifyCNV tools and sampling-based <italic toggle="yes">P</italic>-value. <monospace>TADeus2</monospace> is publicly available at <ext-link xlink:href="https://tadeus2.mimuw.edu.pl" ext-link-type="uri">https://tadeus2.mimuw.edu.pl</ext-link>.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>Main functionalities offered by TADeus2 together with their integration within the clinical workflow for the pathogenicity assessment of structural variations disarranging 3D chromatin structure.</p>
          </caption>
          <graphic xlink:href="gkac318figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Science Centre</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004281</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NCN 2019/33/N/ST6/03110</award-id>
        <award-id>NCN 2018/30/M/NZ2/00054</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Foundation for Polish Science</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001870</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <sec id="SEC1-1">
      <title>Motivation</title>
      <p>Next generation sequencing (NGS) revolutionized the field of clinical genetics (<xref rid="B1" ref-type="bibr">1</xref>). One of the most popular approaches in the identification of molecular etiology of human diseases is sequencing of coding regions, which compose &lt;3% of the genome (<xref rid="B2" ref-type="bibr">2</xref>). However, the application of whole exome sequencing (WES) characterized the genotype-phenotype correlation in only 25–40% of patients (<xref rid="B3" ref-type="bibr">3</xref>). This diagnostic rate could be explained by the limitation in WES targeting only coding regions, while other causes of pathology such as structural variants (SVs) and copy number variants (CNVs) are often located in non-coding DNA (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>).</p>
      <p>SV and CNV might lead to disease through 4 main mechanisms: (i) direct disruption or deletion of a gene leading to haploinsufficiency (<xref rid="B6" ref-type="bibr">6</xref>); (ii) generation of SV/CNV derived fusion genes – a mechanism often present, but not limited to cancer cells (<xref rid="B7" ref-type="bibr">7–9</xref>); (iii) changes in the gene dosage due to duplication (<xref rid="B10" ref-type="bibr">10</xref>) and (iv) disruption of the epigenetic equilibrium caused by displacement of regulatory elements (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). The latter mechanism is often caused by changes in the three-dimensional (3D) chromatin structure. The 3D genome architecture controls spatiotemporal gene expression and plays a key role in the development and disease (<xref rid="B13" ref-type="bibr">13</xref>). At the (sub)megabase scale, the 3D chromatin structure is organized into topologically associated domains (TADs), delimited by boundaries enriched in CTCF binding sites (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>). TADs facilitate enhancer-promoter contacts within their bodies and insulate inter-TADs chromatin interactions (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>).</p>
      <p>Interestingly, the disruption of TADs or the formation of a novel TADs can lead to gene deregulation associated with congenital disorders e.g. brachydactyly, a limb malformation affecting finger development (<xref rid="B17" ref-type="bibr">17</xref>), and Cooks syndrome, a congenital disorder affecting digits and nails (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <p>Despite the characterization of the genotype-phenotype correlation in a number of diseases linked to SVs and CNVs in non-coding DNA, the evaluation of their pathogenicity caused by the disruption of long-range regulatory interactions remains challenging (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B19" ref-type="bibr">19</xref>). More evidence points towards the fact that computational investigation of non-coding variants severity is helpful in the diagnosis of genetic disorders (<xref rid="B20" ref-type="bibr">20–22</xref>).</p>
      <p>For this reason, there is a clear need for an easy to use web server that enables a quick evaluation of chromatin conformation changes and provides a visual framework for the interpretation of SVs/CNVs affecting TADs structures.</p>
    </sec>
    <sec id="SEC1-2">
      <title>Related research</title>
      <p>The growing number of NGS data from symptomatic SVs/CNVs carriers led to the emergence of multiple databases inspiring further studies regarding the role of gene position effect (GPE) in the patient phenotype. For example, Zepada et. al. applied the haploinsufficiency and triplosensivity scores to characterize GPE derived from balanced translocations in 17 subjects from the Developmental Genome Anatomy Project (GDAP) (<xref rid="B23" ref-type="bibr">23</xref>). Ruifeng <italic toggle="yes">et al.</italic> using data from ClinVar database (<xref rid="B24" ref-type="bibr">24</xref>) introduced the Structure Influence score to prioritize and designate SVs that are likely to disturb gene regulation through TADs disorganization. Salem et al. (<xref rid="B25" ref-type="bibr">25</xref>) based on the DECIPHER database (containing nearly one thousand deletions) (<xref rid="B26" ref-type="bibr">26</xref>) showed that only 4.5% of analyzed deletions can disrupt TAD boundaries leading to the gene misexpression due to enhancer adoption.</p>
      <p>Investigation of NGS data from symptomatic patients carrying SVs led also to the development of multiple tools designed for clinical evaluation of SVs, including: 3Disease Browser (<xref rid="B27" ref-type="bibr">27</xref>), PhenogramViz (<xref rid="B28" ref-type="bibr">28</xref>), GeCCO (<xref rid="B29" ref-type="bibr">29</xref>) or rankings based on HI scores (<xref rid="B30" ref-type="bibr">30</xref>). However, PhenogramViz, GeCCO and HI scores do not use the chromatin conformation and regulatory data for the SV-induced pathogenecity estimation, while 3Disease Browser does not evaluate any novel SVs.</p>
      <p>Among the newest web-services providing an extended palette of features for SVs/CNVs evaluation in the clinical context are 3D Genome Browser (<xref rid="B31" ref-type="bibr">31</xref>) and CNVxplorer (<xref rid="B32" ref-type="bibr">32</xref>). The main functionalities provided by 3D Genome Browser consist of analysis of disease-associated SVs and 3D chromatin structure by visualization and integration of Hi-C and ChIP-seq data. This tool also enables inspection of inter-chromosomal interactions. However, it is limited only to the uni-directed strand view (hg19), and does not provide any views for comparisons of the rearranged genome structure versus wild-type. The CNVxplorer mines a comprehensive set of clinical, genomic, and epigenomic features associated with CNVs making it one of the most versatile diagnosis tools available online. Nonetheless, it focuses only on CNVs and does not consider balanced rearrangements events. Summarized evaluation of tools with purpose comparable to <monospace>TADeus2</monospace> is presented in the Table <xref rid="tbl1" ref-type="table">1</xref>.</p>
      <table-wrap position="float" id="tbl1">
        <label>Table 1.</label>
        <caption>
          <p>Listing of all available tools that provide similar functionalities to <monospace>TADeus2</monospace> regarding typical clinical use cases, TAD analysis and breakpoint viewing</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">
                <break/>
              </th>
              <th colspan="4" align="center" rowspan="1">Options</th>
              <th rowspan="1" colspan="1">
                <break/>
              </th>
              <th colspan="4" align="center" rowspan="1">Breakpoint browser options</th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">Name of service</th>
              <th rowspan="1" colspan="1">HiC Heat map</th>
              <th rowspan="1" colspan="1">Tad<break/>annotation</th>
              <th rowspan="1" colspan="1">Virtual 4C view</th>
              <th rowspan="1" colspan="1">Data upload or local installation</th>
              <th rowspan="1" colspan="1">Breakpoint browser mode</th>
              <th rowspan="1" colspan="1">Wildtype View</th>
              <th rowspan="1" colspan="1">Customised Tracks</th>
              <th rowspan="1" colspan="1">Unlimited Number HiC tracks</th>
              <th rowspan="1" colspan="1">Head/Tail Orientation of coordinates</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <monospace>TADeus<sup>b</sup></monospace>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3D Genome Browser<sup>a</sup> (<xref rid="B31" ref-type="bibr">31</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
                <sup>b</sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3DIV<sup>c</sup> (<xref rid="B33" ref-type="bibr">33</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HiGlass (<xref rid="B34" ref-type="bibr">34</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Juicebox (<xref rid="B35" ref-type="bibr">35</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">
                  <inline-formula>
                    <tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                  </inline-formula>
                </italic>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">WashU Epigenome Browser (<xref rid="B36" ref-type="bibr">36</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HUGIN (<xref rid="B37" ref-type="bibr">37</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3Disease Browser (<xref rid="B38" ref-type="bibr">38</xref>)</td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula>
                  <tex-math id="M00033" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
                </inline-formula>
              </td>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T1TFN1">
            <p><sup>a</sup>Inter-chromosomal interaction mode is regarded as breakpoint mode for comparisons.</p>
          </fn>
          <fn id="T1TFN2">
            <p><sup>b</sup>As UCSC or WashU session link.</p>
          </fn>
          <fn id="T1TFN3">
            <p><sup>c</sup>Complex SV and 3D genome view is regarded as breakpoint mode for comparisons.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="SEC1-3">
      <title>Our results</title>
      <p>To address existing challenges and provide a competitive tool, we have developed <monospace>TADeus2</monospace>—a web server for a quick evaluation of SVs/CNVs that provides a visual framework to aid the medical expert in the interpretation of variant pathogenicity in the context of changes in the TADs organization (see Graphical Abstract). Based on the type of a variant <monospace>TADeus2</monospace> allows to visualize the affected region in two modes: (i) <italic toggle="yes">syntenic</italic> mode dedicated for the analysis of deletions and duplications; (ii) <italic toggle="yes">breakpoint</italic> mode designed for translocations and inversions. The former mode allows visualization of one genomic region, while the latter enables analysis of two different genome loci joined together during the rearrangement event. Both modes integrate multiple datasets (e.g. Hi-C or ChIPseq) either available on the server or provided by the user. The tool is user-friendly and allows to perform a customized analysis by providing the genomic coordinates of the analyzed variants. It should be emphasized that <monospace>TADeus2</monospace> and its previous version <monospace>TADeus</monospace> (<xref rid="B39" ref-type="bibr">39</xref>) was successfully used in the recently published studies (<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Publicly available experimental data</title>
      <p>Currently, <monospace>TADeus2</monospace> allows the user to upload genomic data in BED and BEDGraph format. The user is also provided with over 30 preloaded, publicly available datasets described in detail at <ext-link xlink:href="https://tadeus2.mimuw.edu.pl/datasources/" ext-link-type="uri">https://tadeus2.mimuw.edu.pl/datasources/</ext-link>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Evaluation of the gene pathogenicity</title>
      <p>To assess and rank the pathogenicity of a gene <monospace>TADeus2</monospace> <italic toggle="yes">score</italic> is introduced. For a given gene <italic toggle="yes">g</italic> its value is calculated based on the following indicators: (i) CG(<italic toggle="yes">g</italic>): the ClinGen haploinsufficiency/triplosensitivity score (<xref rid="B42" ref-type="bibr">42</xref>), (ii) EPdis(<italic toggle="yes">g</italic>): the number of distant candidate enhancer–promoter predicted interactions disrupted by the breakpoints based on (<xref rid="B43" ref-type="bibr">43</xref>), (iii) HPO(<italic toggle="yes">g</italic>): the number of names and links to the associated phenotype described in Human Phenotype Ontology (HPO)—the ontology of phenotypic abnormalities with associated diseases and genes (<xref rid="B44" ref-type="bibr">44</xref>), (iv) dist(<italic toggle="yes">g</italic>): the distance from the rearrangement breakpoints. The final formula is accordingly a scaled sum of the four compounds:<disp-formula><tex-math id="M00034" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} score(g) &amp;=&amp; \mathbb {I} (\rm{CG}(g) = 1 ) + \mathbb {I} (\rm{EPdis}(g) &gt; 0 ) \\ &amp;&amp; +\, \mathbb {I} (\rm{HPO}(g) &gt; 0 ) + \mathbb {I} (\rm{dist}(g) &lt; {1} \rm{Mb}), \end{eqnarray*}$$\end{document}</tex-math></disp-formula>where CG(<italic toggle="yes">g</italic>) is equal to 1 when <italic toggle="yes">g</italic> falls into one of the ClinGen categories: Sufficient Evidence, Emerging Evidence, Autosomal Recessive; and <inline-formula><tex-math id="M00035" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathbb {I}(c) = 1$\end{document}</tex-math></inline-formula>, when a condition <italic toggle="yes">c</italic> is met and 0 otherwise.</p>
      <p>As an example consider gene <italic toggle="yes">g</italic> = TBR1 ranked as first in evaluation of structural variant involving chromosome 2 (exemplary case study from the main page of the web service). This gene is annotated in ClinGen, so CG(<italic toggle="yes">g</italic>) = 1, there are 38 disrupted distant enhancer-promoter interactions, i.e. EPdis(<italic toggle="yes">g</italic>) &gt; 0, also the HPO(<italic toggle="yes">g</italic>) &gt; 0 as several abnormal phenotypes have been found in HPO, and finally the distance of the TBR1 gene from the breakpoint is small enough, i.e. dist(<italic toggle="yes">g</italic>) &lt; 1Mb. In total we get a Total Pathogenecity Score equal to 4.</p>
    </sec>
    <sec id="SEC2-3">
      <title><monospace>TADeus2</monospace> rank gene table</title>
      <p>The table is ordered by the aforementioned ranking score in the descending order. Genes with the equal scores are secondary sorted by the number of the disrupted enhancer–promoter interactions and the distance from the rearrangement breakpoints. For the convenience of the user the final importance ranking is color-coded with a dark-pink to white scale. Additionally, for a broader perspective, the disease and inheritance type from Online Mendelian Inheritance in Man (OMIM) (<xref rid="B45" ref-type="bibr">45</xref>) and pLI score from Genome Aggregation Database (gnomAD) (<xref rid="B46" ref-type="bibr">46</xref>), were added.</p>
    </sec>
    <sec id="SEC2-4">
      <title>SVs/CNVs pathogenicity assessment</title>
      <p>To evaluate the pathogenicity of a rearrangement <monospace>TADeus2</monospace> uses the state-of-the-art, third-party software: TADA (available only for autosomes) (<xref rid="B47" ref-type="bibr">47</xref>) and ClassifyCNV (<xref rid="B48" ref-type="bibr">48</xref>) as well as an original statistical significance p-value.</p>
      <p>TADA automatically ranks Copy Number Variants (CNVs) based on a extensive catalogue of functional annotations supported by enrichment analysis. The software is based on a machine-learning classifier to accurately predict and prioritize pathogenic deletion or duplication to produce a well-calibrated pathogenicity score.</p>
      <p>ClassifyCNV, uses pre-parsed publicly available databases to calculate a pathogenicity score for each duplication and deletion. Importantly, the tool is an implementation of the 2019 ACMG guidelines for variant interpretation that provide a set of criteria to score variants and place them into one of the five classification tiers (<xref rid="B49" ref-type="bibr">49</xref>).</p>
      <p>Finally, we propose calculation of an empirical <italic toggle="yes">p</italic>-value to assess the statistical significance of the predicted number of interrupted interactions between the <italic toggle="yes">cis</italic>-regulatory elements, which is a good predictor of SVs pathogenicity (<xref rid="B50" ref-type="bibr">50</xref>).</p>
      <p>To this end we compute the null hypothesis probability distribution—the probability distribution for all possible numbers of disrupted interactions induced by a random breakpoint. We sample 10<sup>4</sup> loci and compute the number of potential disruptions that would occur because of a breakpoint in that loci. The resulting distribution is approximated by a mixture of the 0-concentrated Dirac distribution and the geometric distribution:<disp-formula><tex-math id="M00036" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} \mathbb {P}(X = k| P, \delta )= \left\lbrace \begin{array}{@{}l@{\quad }l@{}}\delta , &amp; {\rm for } k=0\\ (1-\delta ) P (1-P) ^ {k-1}, &amp; {\rm for } k &gt; 0\\ 0, &amp; {\rm for } k &lt; 0 \end{array} \right. \end{eqnarray*}$$\end{document}</tex-math></disp-formula>for some <italic toggle="yes">P</italic> ∈ (0, 1) and δ ∈ (0, 1) parameters, which we estimated from the data. The proportion of breakpoints in all genome loci that do not disrupt any predicted promoter–enhancer interactions is an estimator of δ (0.0924), while <italic toggle="yes">P</italic> (0.01174) was estimated as the maximum likelihood estimation (MLE). As a result, the smallest number of enhancer–promoter interactions broken by a rearrangement breakpoint that is statistically significant (i.e. <italic toggle="yes">P</italic>-value ≤ 0.05) is equal to 246.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Implementation and architecture of <monospace>TADeus2</monospace> web server</title>
      <p><monospace>TADeus2</monospace> is implemented as a Django application using MySQL database as data storage. Fragments of code from HiCExplorer (<xref rid="B51" ref-type="bibr">51</xref>) are reused in the track plot module. All the presented command-line tools (e.g. TADA, classifyCNV) incorporated in <monospace>TADeus2</monospace> are accompanied with a responsive and user-friendly graphical interface developed with Bootstrap v4. Additionally, java-script snippets enable customization of forms and export of any user-defined plots that are produced using the python matplotlib package. Finally, <monospace>TADeus2</monospace> provides the rest-API that can be utilized by external applications.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS AND DISCUSSION</title>
    <sec id="SEC3-1">
      <title>Diagnosis workflow of <monospace>TADeus2</monospace> web server</title>
      <p>The input of <monospace>TADeus2</monospace> consists of breakpoint coordinates (hg38) previously identified experimentally. The analysis starts with the selection of an adequate Hi-C matrix (currently, data from 8 different cell-types are available). The Hi-C matrix is displayed as <italic toggle="yes">a triangle plot</italic> (upper triangle rotated by 45°) and TADs structure is visualized (red lines), in order to investigate the SV role in reorganization of the domains (often linked to symptomatic gene misexpression). Based on the type of a variant the user should choose either <italic toggle="yes">syntenic</italic> mode (deletion or duplication), or <italic toggle="yes">breakpoint</italic> mode (translocation, inversion). The former, presents a continuous sequence of a genomic region and is designed to generate a ranked table of putative disease-causing genes. The latter integrates two genomic fragments from different loci (e.g. located at distinct chromosomes) as if it was a continuous genome chunk, allowing visualization of the new rearrangement. To use this mode the user should specify the coordinates of the breakpoints and the direction of the fused strands (e.g. in the case of translocation between <italic toggle="yes">P</italic> and <italic toggle="yes">q</italic> arms, a forward reverse strand fusion occurs). The breakpoint view also includes wild-type regions that compose the rearrangement. Further analysis (in both modes) includes an integration of additional tracks containing publicly available or self-uploaded datasets. After the selection of disease causing putative genes (based on the <monospace>TADeus2</monospace>rank gene table or the interpretation of particular tracks e.g. gnomAD pLI) the user should focus on the characterization of the cis-regulatory landscape within the region of interest. This can be achieved by: (i) identification of candidate enhancers (CEs) based on the histone marks (H3K27ac, H3K4me1), chromatin accessibility (DNAseI), and conservation; (ii) investigation of the track with experimentally validated enhancers; (iii) analysis of putative enhancer-promoter interactions based on Virtual 4C. Finally, verification of the regulatory elements, enhancer-promoter interactions, disrupted genes should be further confirmed experimentally. For the convenience of the reader, the overview of the clinical diagnosis workflow is also presented in Figure <xref rid="F1" ref-type="fig">1</xref>.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p><monospace>TADeus2</monospace> overview of the clinical diagnosis workflow. The above diagram outlines the subsequent steps recommended for the SVs/CNVs evaluation. The pipeline starts with the specification of a pair of coordinates accompanied by a Hi-C matrix of interest. Using two different views the structural rearrangements can be visualized and inspected. Next, based on numerous indicators of disease-causing putative genes candidates for further analysis can be selected. Finally, position effects can be evaluated thanks to provided databases from UCSC e.g. H3K27ac or experimentally verified regulatory elements. All the obtained outcomes are candidates for any further confirmation with wet experiments.</p>
        </caption>
        <graphic xlink:href="gkac318fig1" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-2">
      <title>Validation of <monospace>TADeus2</monospace> gene ranking scheme</title>
      <p>In order to test <monospace>TADeus2</monospace> accuracy a detailed search of literature was performed to find well-described cases of position effects generated by SVs and CNVs. For each case, breakpoints, clinical presentation and genes that according to authors contribute to the disease were collected. A table ranking disease-causing putative genes close to the SV/CNV was generated only for the chromosome where the disease causing gene was present. In total, 21 distinct cases were found and used to validate the <monospace>TADeus2</monospace> ranking method (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). For 18 (85.7%) cases, the genes contributing to the disease were predicted as the strongest candidates (top scores if compared to the rest of the genes localized on the same chromosome). In the remaining 3 (14.3%) cases, genes were predicted as the most probable candidates with lower scores (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
      <p>Below we present in detail two selected cases from the set described above.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Examples of analysis workflows provided by <monospace>TADeus2</monospace> in a clinical diagnosis setting</title>
      <sec id="SEC3-3-1">
        <title>Case 1—Position effect in a balanced translocation neighbouring <italic toggle="yes">FOXG1</italic> gene</title>
        <p>Murcia Pienkowski <italic toggle="yes">et al.</italic> identified the exact structure of a balanced chromosomal translocation (46,XX,t(6;14)(p25.1;q12)) in a patient with epileptic seizures and severe developmental delay (<xref rid="B40" ref-type="bibr">40</xref>). The breakpoint on chromosome 6 disrupted the<italic toggle="yes">TXNDC5</italic> gene in the second intron (chr6:7903201 hg38), while chromosome 14 was damaged in non-coding DNA (chr14:29266318). <monospace>TADeus2</monospace> ranking was used to establish genes that have a higher probability of being responsible for the disease. On chromosome 6 the highest score was assigned to gene DSP. At the same time on chromosome 14 <italic toggle="yes">FOXG1</italic> was chosen as the gene with the highest probability to impact the phenotype (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
        <p>Based on the clinical picture that the patient displayed we decided to conduct the next steps of the analysis using data Hi-C from neural progenitor cells (NPC). The following tracks have been added to the breakpoint view: Genes coloured by pLI score, Virtual 4C for promoter regions (±2.5 kb from transcription start site (TSS)) for <italic toggle="yes">DSP</italic> and <italic toggle="yes">FOXG1</italic> and experimentally validated functional elements from NCBI database (Figure <xref rid="F2" ref-type="fig">2</xref>). The result indicate that <italic toggle="yes">FOXG1</italic> lost contact with 4 experimentally verified enhancers, while <italic toggle="yes">DSP</italic> did not lose any, making <italic toggle="yes">FOXG1</italic> the most probable cause of the disease (see the red box in Figure <xref rid="F2" ref-type="fig">2</xref>). Indeed, at least 11 translocations located in proximity of <italic toggle="yes">FOXG1</italic> in patients with Rett-like syndrome have been described. Furthermore, it has been proposed that loss of only one active <italic toggle="yes">FOXG1</italic> enhancer is not clinically relevant (<xref rid="B52" ref-type="bibr">52</xref>). This is consistent with our results as the analyzed translocation leads to displacement of two apparently important enhancers: hs433 and hs342; and two enhancers with unknown impact on textitFOXG1: hs1168 and hs598. hs433 is thought to bring other enhancers into physical contact with <italic toggle="yes">FOXG1</italic> (<xref rid="B53" ref-type="bibr">53</xref>), while hs342 is the main candidate for the regulation of <italic toggle="yes">FOXG1</italic> expression (<xref rid="B52" ref-type="bibr">52</xref>). Overall, <monospace>TADeus2</monospace> indicated correctly the gene responsible for the disease as well as important regulatory elements that might have been at the root of the patient phenotype. Importantly, further experimental investigation of <italic toggle="yes">cis</italic>-regulatory landscape encompassing FOXG1 might shed more light into the etiology of the patients phenotype.</p>
        <fig position="float" id="F2">
          <label>Figure 2.</label>
          <caption>
            <p>Analysis of a balanced translocation 46,XX,t(6;14)(p25.1;q12) in a patient with epileptic seizures and severe developmental delay. Visualization of the fusion chromosome der(14) (<bold>A</bold>) and wild type chromosomes: chromosome 14 (<bold>B</bold>) chromosome 6 (<bold>C</bold>). NPC Hi-C data was used to generate the chromatin architecture (top track). The figure contains the following tracks: gene gnomAD pLI score (bottom track) in color-scale (0 = blue and 1 = red), virtual 4C for promoter regions (±2.5 kb from TSS) for FOXG1 and DSP and experimentally validated functional elements. The enhancers displaced by the translocation are marked with the red rectangle.</p>
          </caption>
          <graphic xlink:href="gkac318fig2" position="float"/>
        </fig>
      </sec>
      <sec id="SEC3-3-2">
        <title>Case 2—Position effect in an inversion accompanied with a deletion located nearby DLX5 and DLX6 genes</title>
        <p>Kerry Brown et al. identified a paracentric inversion of the long arm of chromosome 7, inv(7)(q21.3q35) in five patients with hearing loss and craniofacial defects (<xref rid="B54" ref-type="bibr">54</xref>). The breakpoint in q21.3 (accompanied by a 5.1 kb deletion (chr7:96,935,329-96,940,443; hg38)) is located within non-coding region, 65–80 kb away from DLX5 and DLX6 genes, while the 7q35 breakpoint disrupts the <italic toggle="yes">CNTNAP2</italic> gene, between exon two and ten.</p>
        <p>First, we used <monospace>TADeus2</monospace> to analyze the potential role of 7q35 breakpoint in the molecular etiology of hearing loss and craniofacial defects. Characterization of the chromatin architecture surrounding the breakpoint region revealed no genes within the TAD except <italic toggle="yes">CNTNAP2</italic> (Figure <xref rid="F3" ref-type="fig">3A</xref>). However, the pLI score for <italic toggle="yes">CNTNAP2</italic> was equal to zero, suggesting that disruption of one copy of <italic toggle="yes">CNTNAP2</italic> has a low probability of being responsible for the abovementioned defects. Indeed, the spatiotemporal expression analysis of <italic toggle="yes">CNTNAP2</italic> during mouse embryonic development revealed no expression in the majority of tissues linked to the patient’s phenotype (<xref rid="B54" ref-type="bibr">54</xref>). Moreover, the <italic toggle="yes">CNTNAP2</italic>-/- mice present no abnormalities in craniofacial and inner ear development (<xref rid="B55" ref-type="bibr">55</xref>). Therefore, for further analysis we focused on the 7q21.3 breakpoint region.</p>
        <fig position="float" id="F3">
          <label>Figure 3.</label>
          <caption>
            <p>Analysis of the inversion inv(7)(q21.3q35) linked to the craniofacial defects and hearing loss. (<bold>A</bold>) Visualisation of the 7q35 breakpoint located between <italic toggle="yes">CNTNAP2</italic> exon two and ten. Stem cell derived myoblasts were used to visualise the chromatin architecture (top track) combined with gene gnomAD pLI score (bottom track) in color-scale (0 = blue and 1 = red). (<bold>B</bold>) Visualisation of the breakpoint in q21.3 located centromeric to DLX5 and DLX6. The Hi-C data was used from stem cell derived myoblasts (top track), followed by analysis of gene gnomAD pLI scores, and also cis-regulatory elements (middle tracks). The putative interactions between DLX5, DLX6 promoters (±2.5 kb from TSS) and non-coding DNA were investigated using Virtual 4C (bottom track). The enhancers affected by inversion are marked with the red rectangle.</p>
          </caption>
          <graphic xlink:href="gkac318fig3" position="float"/>
        </fig>
        <p>The <monospace>TADeus2</monospace> ranking list pointed DLX5 and DLX6 as genes with a high probability of being responsible for these developmental abnormalities (top two genes with rank score: 300), with the pLI score equal to 0.2184 and 0.9213, respectively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Based on these results we extended our analysis by implementing the <monospace>TADeus2</monospace> browser tracks with: experimentally validated functional elements from NCBI database and virtual 4C for <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> promoter regions (±2.5 kb from TSS). Multiple enhancers are located within the genomic region affected by the inversion, and in close 3D proximity with <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> promoters (based on virtual 4C).</p>
        <p>This suggests that the inversion might disrupt long-range contacts between six experimentally validated enhancers (in the red rectangle) and promoters of <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic>, most likely leading to a misregulation of these two genes (Figure <xref rid="F3" ref-type="fig">3B</xref>).</p>
        <p>Importantly, <italic toggle="yes">DLX5</italic> is expressed in the otic placode and vesicle (involved in formation of inner ear vestibular structures), and in the semicircular canals of the inner ear (<xref rid="B56" ref-type="bibr">56</xref>). Deletion of <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> leads to dysplastic ears and congenital deafness (Chromosome 7 Annotation Project, <ext-link xlink:href="http://www.chr7.org" ext-link-type="uri">http://www.chr7.org</ext-link>), which is consistent with the mouse phenotype. The <italic toggle="yes">DLX5</italic> knockout as well as <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> double knockout mice are characterized by the craniofacial malformations and abnormalities in the ear development (<xref rid="B56" ref-type="bibr">56–58</xref>). Collectively, <monospace>TADeus2</monospace> results align with literature results suggesting that changes in the <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> gene dosage caused by disruption of enhancer-promoter connections may lead to the patient phenotype.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC4">
    <title>CONCLUSIONS AND FUTURE PLANS</title>
    <p>In the following article we presented <monospace>TADeus2</monospace> web server with all its features. The tool is an online solution for visualization and analysis of SVs and CNVs in the context of chromatin conformation. Thanks to an easy to use and user-friendly interface, <monospace>TADeus2</monospace> is suitable as a handful framework for preliminary clinical diagnosis of patients for non-bioinformatician experts.</p>
    <p>The future directions for the improvement of the web server include additional expansions of the breakpoint view that would allow the view of more breakpoint coordinates at once (particularly useful for visualisation of inversions, duplications, and complex rearrangements, i.e. chromothripsis). In addition, we plan to implement a functionality that provides a visualization of chromatin conformation in 3D.</p>
    <p>Moreover, to predict the TAD structure affected by the SVs, Akita software (<xref rid="B59" ref-type="bibr">59</xref>) will be used to generate a new Hi-C matrix for the rearranged TAD. This functionality is currently under development, with a beta version available for the user.</p>
    <p>Furthermore, the statistical modeling of chromatin organization disorders caused by structural variants will be further developed to achieve higher accuracy in its assessment. Lastly, we state that <monospace>TADeus2</monospace> will benefit from regular updates using the wealth of data publicly available.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p><monospace>TADeus2</monospace> is publicly available at <ext-link xlink:href="https://tadeus2.mimuw.edu.pl" ext-link-type="uri">https://tadeus2.mimuw.edu.pl</ext-link>. Detailed tutorial, help pages, short videos presenting functionality of application, and a FAQ section are provided. The tool is free and open to all users and there is no login requirement. <monospace>TADeus2</monospace> source code and installation instructions are available at <ext-link xlink:href="https://github.com/bposzewiecka/tadeus2" ext-link-type="uri">https://github.com/bposzewiecka/tadeus2</ext-link>. The software is distributed under a GNU General Public License v3.0.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac318_Supplemental_Files</label>
      <media xlink:href="gkac318_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>Authors want to thank Paweł Stankiewicz (Baylor College of Medicine) and Tomasz Gambin (Warsaw University of Technology) for their invaluable contribution to the development of the first version of the <monospace>TADeus</monospace> tool.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac318#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>B.P. was supported by the grant of National Science Centre [NCN 2019/33/N/ST6/03110]; K.G. and A.G. were supported by the grant of National Science Centre [NCN 2018/30/M/NZ2/00054]; V.M.P. is supported by the Foundation for Polish Science, START Programme and MarMaRa grant. Funding for open access charge: Polish National Science Centre [NCN 2018/30/M/NZ2/00054].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chiodini</surname><given-names>R.</given-names></string-name>, <string-name><surname>Badr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>G.</given-names></string-name></person-group><article-title>The impact of next-generation sequencing on genomics</article-title>. <source>J. Genet. Genomics.</source><year>2011</year>; <volume>38</volume>:<fpage>95</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">21477781</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hangauer</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Vaughn</surname><given-names>I.W.</given-names></string-name>, <string-name><surname>McManus</surname><given-names>M.T.</given-names></string-name></person-group><article-title>Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs</article-title>. <source>PLoS Genet.</source><year>2013</year>; <volume>9</volume>:<fpage>e1003569</fpage>.<pub-id pub-id-type="pmid">23818866</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sawyer</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hartley</surname><given-names>T.</given-names></string-name>, <string-name><surname>Dyment</surname><given-names>D.</given-names></string-name>, <string-name><surname>Beaulieu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Schwartzentruber</surname><given-names>J.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bedford</surname><given-names>H.</given-names></string-name>, <string-name><surname>Bernard</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bernier</surname><given-names>F.</given-names></string-name>, <string-name><surname>Brais</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care</article-title>. <source>Clin. Genet.</source><year>2016</year>; <volume>89</volume>:<fpage>275</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">26283276</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kumar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Adhikari</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kankainen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Heckman</surname><given-names>C.A.</given-names></string-name></person-group><article-title>Comparison of structural and short variants detected by linked-read and whole-exome sequencing in multiple Myeloma</article-title>. <source>Cancers</source>. <year>2021</year>; <volume>13</volume>:<fpage>1212</fpage>.<pub-id pub-id-type="pmid">33802025</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zare</surname><given-names>F.</given-names></string-name>, <string-name><surname>Dow</surname><given-names>M.</given-names></string-name>, <string-name><surname>Monteleone</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hosny</surname><given-names>A.</given-names></string-name>, <string-name><surname>Nabavi</surname><given-names>S.</given-names></string-name></person-group><article-title>An evaluation of copy number variation detection tools for cancer using whole exome sequencing data</article-title>. <source>BMC bioinformatics</source>. <year>2017</year>; <volume>18</volume>:<fpage>286</fpage>.<pub-id pub-id-type="pmid">28569140</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harewood</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chaignat</surname><given-names>E.</given-names></string-name>, <string-name><surname>Reymond</surname><given-names>A.</given-names></string-name></person-group><article-title>Structural variation and its effect on expression</article-title>. <source>Methods Mol. Biol.</source><year>2012</year>; <volume>838</volume>:<fpage>173</fpage>–<lpage>186</lpage>.<pub-id pub-id-type="pmid">22228012</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitelman</surname><given-names>F.</given-names></string-name>, <string-name><surname>Johansson</surname><given-names>B.</given-names></string-name>, <string-name><surname>Mertens</surname><given-names>F.</given-names></string-name></person-group><article-title>The impact of translocations and gene fusions on cancer causation</article-title>. <source>Nat. Rev. Cancer</source>. <year>2007</year>; <volume>7</volume>:<fpage>233</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">17361217</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mertens</surname><given-names>F.</given-names></string-name>, <string-name><surname>Johansson</surname><given-names>B.</given-names></string-name>, <string-name><surname>Fioretos</surname><given-names>T.</given-names></string-name>, <string-name><surname>Mitelman</surname><given-names>F.</given-names></string-name></person-group><article-title>The emerging complexity of gene fusions in cancer</article-title>. <source>Nat. Rev. Cancer</source>. <year>2015</year>; <volume>15</volume>:<fpage>371</fpage>–<lpage>381</lpage>.<pub-id pub-id-type="pmid">25998716</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eykelenboom</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>G.J.</given-names></string-name>, <string-name><surname>Bradshaw</surname><given-names>N.J.</given-names></string-name>, <string-name><surname>Soares</surname><given-names>D.C.</given-names></string-name>, <string-name><surname>Ogawa</surname><given-names>F.</given-names></string-name>, <string-name><surname>Christie</surname><given-names>S.</given-names></string-name>, <string-name><surname>Malavasi</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Makedonopoulou</surname><given-names>P.</given-names></string-name>, <string-name><surname>Mackie</surname><given-names>S.</given-names></string-name>, <string-name><surname>Malloy</surname><given-names>M.P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A t (1; 11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins</article-title>. <source>Hum. Mol. Genet.</source><year>2012</year>; <volume>21</volume>:<fpage>3374</fpage>–<lpage>3386</lpage>.<pub-id pub-id-type="pmid">22547224</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lupski</surname><given-names>J.R.</given-names></string-name></person-group><article-title>Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity</article-title>. <source>Pediatr. Res.</source><year>1999</year>; <volume>45</volume>:<fpage>159</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">10022584</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harewood</surname><given-names>L.</given-names></string-name>, <string-name><surname>Schütz</surname><given-names>F.</given-names></string-name>, <string-name><surname>Boyle</surname><given-names>S.</given-names></string-name>, <string-name><surname>Perry</surname><given-names>P.</given-names></string-name>, <string-name><surname>Delorenzi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bickmore</surname><given-names>W.A.</given-names></string-name>, <string-name><surname>Reymond</surname><given-names>A.</given-names></string-name></person-group><article-title>The effect of translocation-induced nuclear reorganization on gene expression</article-title>. <source>Genome Res.</source><year>2010</year>; <volume>20</volume>:<fpage>554</fpage>–<lpage>564</lpage>.<pub-id pub-id-type="pmid">20212020</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harewood</surname><given-names>L.</given-names></string-name>, <string-name><surname>Fraser</surname><given-names>P.</given-names></string-name></person-group><article-title>The impact of chromosomal rearrangements on regulation of gene expression</article-title>. <source>Hum. Mol. Genet.</source><year>2014</year>; <volume>23</volume>:<fpage>R76</fpage>–<lpage>R82</lpage>.<pub-id pub-id-type="pmid">24907073</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aigner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Müller</surname><given-names>G.</given-names></string-name>, <string-name><surname>Knapp</surname><given-names>E.</given-names></string-name>, <string-name><surname>Raas</surname><given-names>E.</given-names></string-name></person-group><article-title>Systolic time intervals, phonocardiograms and sound spectrograms in patients with Starr-Edwards aortic valve prostheses</article-title>. <source>Cardiology</source>. <year>1974</year>; <volume>59</volume>:<fpage>30</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">4422840</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dixon</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Selvaraj</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yue</surname><given-names>F.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>B.</given-names></string-name></person-group><article-title>Topological domains in mammalian genomes identified by analysis of chromatin interactions</article-title>. <source>Nature</source>. <year>2012</year>; <volume>485</volume>:<fpage>376</fpage>–<lpage>380</lpage>.<pub-id pub-id-type="pmid">22495300</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Ke</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Key role for CTCF in establishing chromatin structure in human embryos</article-title>. <source>Nature</source>. <year>2019</year>; <volume>576</volume>:<fpage>306</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">31801998</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flavahan</surname><given-names>W.A.</given-names></string-name>, <string-name><surname>Drier</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Johnstone</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Hemming</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Tarjan</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Hegazi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shareef</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Javed</surname><given-names>N.M.</given-names></string-name>, <string-name><surname>Raut</surname><given-names>C.P.</given-names></string-name>, <string-name><surname>Eschle</surname><given-names>B.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs</article-title>. <source>Nature</source>. <year>2019</year>; <volume>575</volume>:<fpage>229</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">31666694</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lupiáñez</surname><given-names>D.G.</given-names></string-name>, <string-name><surname>Kraft</surname><given-names>K.</given-names></string-name>, <string-name><surname>Heinrich</surname><given-names>V.</given-names></string-name>, <string-name><surname>Krawitz</surname><given-names>P.</given-names></string-name>, <string-name><surname>Brancati</surname><given-names>F.</given-names></string-name>, <string-name><surname>Klopocki</surname><given-names>E.</given-names></string-name>, <string-name><surname>Horn</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kayserili</surname><given-names>H.</given-names></string-name>, <string-name><surname>Opitz</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Laxova</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions</article-title>. <source>Cell</source>. <year>2015</year>; <volume>161</volume>:<fpage>1012</fpage>–<lpage>1025</lpage>.<pub-id pub-id-type="pmid">25959774</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Franke</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ibrahim</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Andrey</surname><given-names>G.</given-names></string-name>, <string-name><surname>Schwarzer</surname><given-names>W.</given-names></string-name>, <string-name><surname>Heinrich</surname><given-names>V.</given-names></string-name>, <string-name><surname>Schöpflin</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kraft</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kempfer</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jerković</surname><given-names>I.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>W.-L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Formation of new chromatin domains determines pathogenicity of genomic duplications</article-title>. <source>Nature</source>. <year>2016</year>; <volume>538</volume>:<fpage>265</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">27706140</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lettice</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Daniels</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>E.</given-names></string-name>, <string-name><surname>Venkataraman</surname><given-names>S.</given-names></string-name>, <string-name><surname>Devenney</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Gautier</surname><given-names>P.</given-names></string-name>, <string-name><surname>Morrison</surname><given-names>H.</given-names></string-name>, <string-name><surname>Fantes</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hill</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>FitzPatrick</surname><given-names>D.R.</given-names></string-name></person-group><article-title>Enhancer-adoption as a mechanism of human developmental disease</article-title>. <source>Hum. Mutat.</source><year>2011</year>; <volume>32</volume>:<fpage>1492</fpage>–<lpage>1499</lpage>.<pub-id pub-id-type="pmid">21948517</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wells</surname><given-names>A.</given-names></string-name>, <string-name><surname>Heckerman</surname><given-names>D.</given-names></string-name>, <string-name><surname>Torkamani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sebat</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>B.</given-names></string-name>, <string-name><surname>Telenti</surname><given-names>A.</given-names></string-name>, <string-name><surname>di Iulio</surname><given-names>J.</given-names></string-name></person-group><article-title>Ranking of non-coding pathogenic variants and putative essential regions of the human genome</article-title>. <source>Nat. Commun.</source><year>2019</year>; <volume>10</volume>:<fpage>5241</fpage>.<pub-id pub-id-type="pmid">31748530</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lupski</surname><given-names>J.R.</given-names></string-name></person-group><article-title>Non-coding genetic variants in human disease</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>; <volume>24</volume>:<fpage>R102</fpage>–<lpage>R110</lpage>.<pub-id pub-id-type="pmid">26152199</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Momozawa</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Mizukami</surname><given-names>K.</given-names></string-name></person-group><article-title>Unique roles of rare variants in the genetics of complex diseases in humans</article-title>. <source>J. Hum. Genet.</source><year>2020</year>; <volume>66</volume>:<fpage>11</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">32948841</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zepeda-Mendoza</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Ibn-Salem</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kammin</surname><given-names>T.</given-names></string-name>, <string-name><surname>Harris</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Rita</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gripp</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>MacKenzie</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Gropman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Graham</surname><given-names>B.</given-names></string-name>, <string-name><surname>Shaheen</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Computational prediction of position effects of apparently balanced human chromosomal rearrangements</article-title>. <source>Am. J. Hum. Genet.</source><year>2017</year>; <volume>101</volume>:<fpage>206</fpage>–<lpage>217</lpage>.<pub-id pub-id-type="pmid">28735859</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Landrum</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Benson</surname><given-names>M.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Chao</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chitipiralla</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hart</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hoffman</surname><given-names>D.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>46</volume>:<fpage>D1062</fpage>–<lpage>D1067</lpage>.</mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ibn-Salem</surname><given-names>J.</given-names></string-name>, <string-name><surname>Köhler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Love</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Chung</surname><given-names>H.-R.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hurles</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Haendel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Washington</surname><given-names>N.L.</given-names></string-name>, <string-name><surname>Smedley</surname><given-names>D.</given-names></string-name>, <string-name><surname>Mungall</surname><given-names>C.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Deletions of chromosomal regulatory boundaries are associated with congenital disease</article-title>. <source>Genome Biol.</source><year>2014</year>; <volume>15</volume>:<fpage>423</fpage>.<pub-id pub-id-type="pmid">25315429</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Firth</surname><given-names>H.V.</given-names></string-name>, <string-name><surname>Richards</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Bevan</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Clayton</surname><given-names>S.</given-names></string-name>, <string-name><surname>Corpas</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rajan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Van Vooren</surname><given-names>S.</given-names></string-name>, <string-name><surname>Moreau</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pettett</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Carter</surname><given-names>N.P.</given-names></string-name></person-group><article-title>DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources</article-title>. <source>Am. J. Hum. Genet.</source><year>2009</year>; <volume>84</volume>:<fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name></person-group><article-title>3Disease Browser: a web server for integrating 3D genome and disease-associated chromosome rearrangement data</article-title>. <source>Sci. Rep.</source><year>2016</year>; <volume>6</volume>:<fpage>34651</fpage>.<pub-id pub-id-type="pmid">27734896</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Köhler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Schoeneberg</surname><given-names>U.</given-names></string-name>, <string-name><surname>Czeschik</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Doelken</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Hehir-Kwa</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Ibn-Salem</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mungall</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Smedley</surname><given-names>D.</given-names></string-name>, <string-name><surname>Haendel</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>P.N.</given-names></string-name></person-group><article-title>Clinical interpretation of CNVs with cross-species phenotype data</article-title>. <source>J. Med. Genet.</source><year>2014</year>; <volume>51</volume>:<fpage>766</fpage>–<lpage>772</lpage>.<pub-id pub-id-type="pmid">25280750</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hehir-Kwa</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Wieskamp</surname><given-names>N.</given-names></string-name>, <string-name><surname>Webber</surname><given-names>C.</given-names></string-name>, <string-name><surname>Pfundt</surname><given-names>R.</given-names></string-name>, <string-name><surname>Brunner</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>Gilissen</surname><given-names>C.</given-names></string-name>, <string-name><surname>de Vries</surname><given-names>B.B.</given-names></string-name>, <string-name><surname>Ponting</surname><given-names>C.P.</given-names></string-name>, <string-name><surname>Veltman</surname><given-names>J.A.</given-names></string-name></person-group><article-title>Accurate distinction of pathogenic from benign CNVs in mental retardation</article-title>. <source>PLoS Comput. Biol.</source><year>2010</year>; <volume>6</volume>:<fpage>e1000752</fpage>.<pub-id pub-id-type="pmid">20421931</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>I.</given-names></string-name>, <string-name><surname>Marcotte</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Hurles</surname><given-names>M.E.</given-names></string-name></person-group><article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <source>PLoS Genet.</source><year>2010</year>; <volume>6</volume>:<fpage>e1001154</fpage>.<pub-id pub-id-type="pmid">20976243</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kuang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>D.</given-names></string-name>, <string-name><surname>Choudhary</surname><given-names>M.N.K.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>151</fpage>.<pub-id pub-id-type="pmid">30286773</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Requena</surname><given-names>F.</given-names></string-name>, <string-name><surname>Abdallah</surname><given-names>H.H.</given-names></string-name>, <string-name><surname>García</surname><given-names>A.</given-names></string-name>, <string-name><surname>Nitschké</surname><given-names>P.</given-names></string-name>, <string-name><surname>Romana</surname><given-names>S.</given-names></string-name>, <string-name><surname>Malan</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rausell</surname><given-names>A.</given-names></string-name></person-group><article-title>CNVxplorer: a web tool to assist clinical interpretation of CNVs in rare disease patients</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W93</fpage>–<lpage>W103</lpage>.<pub-id pub-id-type="pmid">34019647</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>I.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>M.-S.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H.</given-names></string-name>, <string-name><surname>Eom</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>D.</given-names></string-name>, <string-name><surname>Jung</surname><given-names>I.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>B.</given-names></string-name></person-group><article-title>3DIV: A 3D-genome Interaction Viewer and database</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D52</fpage>–<lpage>D57</lpage>.<pub-id pub-id-type="pmid">29106613</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kerpedjiev</surname><given-names>P.</given-names></string-name>, <string-name><surname>Abdennur</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lekschas</surname><given-names>F.</given-names></string-name>, <string-name><surname>McCallum</surname><given-names>C.</given-names></string-name>, <string-name><surname>Dinkla</surname><given-names>K.</given-names></string-name>, <string-name><surname>Strobelt</surname><given-names>H.</given-names></string-name>, <string-name><surname>Luber</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Ouellette</surname><given-names>S.B.</given-names></string-name>, <string-name><surname>Azhir</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>HiGlass: web-based visual exploration and analysis of genome interaction maps</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>125</fpage>.<pub-id pub-id-type="pmid">30143029</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Durand</surname><given-names>N.C.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Shamim</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Machol</surname><given-names>I.</given-names></string-name>, <string-name><surname>Mesirov</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Lander</surname><given-names>E.S.</given-names></string-name>, <string-name><surname>Aiden</surname><given-names>E.L.</given-names></string-name></person-group><article-title>Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom</article-title>. <source>Cell Syst.</source><year>2016</year>; <volume>3</volume>:<fpage>99</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">27467250</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Purushotham</surname><given-names>D.</given-names></string-name>, <string-name><surname>Sears</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>T.</given-names></string-name></person-group><article-title>WashU epigenome browser update 2019</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>W158</fpage>–<lpage>W165</lpage>.<pub-id pub-id-type="pmid">31165883</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Reiner</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Mohlke</surname><given-names>K.L.</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name></person-group><article-title>HUGIn: Hi-C unifying genomic interrogator</article-title>. <source>Bioinformatics</source>. <year>2017</year>; <volume>33</volume>:<fpage>3793</fpage>–<lpage>3795</lpage>.<pub-id pub-id-type="pmid">28582503</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name></person-group><article-title>3Disease Browser: a web server for integrating 3D genome and disease-associated chromosome rearrangement data</article-title>. <source>Sci. Rep.</source><year>2016</year>; <volume>6</volume>:<fpage>34651</fpage>.<pub-id pub-id-type="pmid">27734896</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Poszewiecka</surname><given-names>B.</given-names></string-name>, <string-name><surname>Stankiewicz</surname><given-names>P.</given-names></string-name>, <string-name><surname>Gambin</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gambin</surname><given-names>A.</given-names></string-name></person-group><article-title>TADeus-a tool for clinical interpretation of structural variants modifying chromatin organization</article-title>. <source>2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)</source>. <year>2018</year>; <publisher-name>IEEE</publisher-name><fpage>84</fpage>–<lpage>87</lpage>.</mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pienkowski</surname><given-names>V.M.</given-names></string-name>, <string-name><surname>Kucharczyk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Młynek</surname><given-names>M.</given-names></string-name>, <string-name><surname>Szczałuba</surname><given-names>K.</given-names></string-name>, <string-name><surname>Rydzanicz</surname><given-names>M.</given-names></string-name>, <string-name><surname>Poszewiecka</surname><given-names>B.</given-names></string-name>, <string-name><surname>Skórka</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sykulski</surname><given-names>M.</given-names></string-name>, <string-name><surname>Biernacka</surname><given-names>A.</given-names></string-name>, <string-name><surname>Koppolu</surname><given-names>A.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Mapping of breakpoints in balanced chromosomal translocations by shallow whole-genome sequencing points to EFNA5, BAHD1 and PPP2R5E as novel candidates for genes causing human Mendelian disorders</article-title>. <source>J. Med. Genet.</source><year>2019</year>; <volume>56</volume>:<fpage>104</fpage>–<lpage>112</lpage>.<pub-id pub-id-type="pmid">30352868</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pienkowski</surname><given-names>V.M.</given-names></string-name>, <string-name><surname>Kucharczyk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rydzanicz</surname><given-names>M.</given-names></string-name>, <string-name><surname>Poszewiecka</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pachota</surname><given-names>K.</given-names></string-name>, <string-name><surname>Młynek</surname><given-names>M.</given-names></string-name>, <string-name><surname>Stawiński</surname><given-names>P.</given-names></string-name>, <string-name><surname>Pollak</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kosińska</surname><given-names>J.</given-names></string-name>, <string-name name-style="given-only"><given-names>Wojciechowska</given-names></string-name><etal>et al</etal>.</person-group><article-title>Breakpoint mapping of symptomatic balanced translocations links the EPHA6, KLF13 and UBR3 genes to novel disease phenotype</article-title>. <source>J. Clin. Med.</source><year>2020</year>; <volume>9</volume>:<fpage>1245</fpage>.</mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehm</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Berg</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>L.D.</given-names></string-name>, <string-name><surname>Bustamante</surname><given-names>C.D.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Landrum</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Ledbetter</surname><given-names>D.H.</given-names></string-name>, <string-name><surname>Maglott</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Nussbaum</surname><given-names>R.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ClinGen—the clinical genome resource</article-title>. <source>N. Engl. J. Med.</source><year>2015</year>; <volume>372</volume>:<fpage>2235</fpage>–<lpage>2242</lpage>.<pub-id pub-id-type="pmid">26014595</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thurman</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Rynes</surname><given-names>E.</given-names></string-name>, <string-name><surname>Humbert</surname><given-names>R.</given-names></string-name>, <string-name><surname>Vierstra</surname><given-names>J.</given-names></string-name>, <string-name><surname>Maurano</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Haugen</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sheffield</surname><given-names>N.C.</given-names></string-name>, <string-name><surname>Stergachis</surname><given-names>A.B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Vernot</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The accessible chromatin landscape of the human genome</article-title>. <source>Nature</source>. <year>2012</year>; <volume>489</volume>:<fpage>75</fpage>.<pub-id pub-id-type="pmid">22955617</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Köhler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vasilevsky</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Engelstad</surname><given-names>M.</given-names></string-name>, <string-name><surname>Foster</surname><given-names>E.</given-names></string-name>, <string-name><surname>McMurry</surname><given-names>J.</given-names></string-name>, <string-name><surname>Aymé</surname><given-names>S.</given-names></string-name>, <string-name><surname>Baynam</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bello</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Boerkoel</surname><given-names>C.F.</given-names></string-name>, <string-name><surname>Boycott</surname><given-names>K.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The human phenotype ontology in 2017</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>45</volume>:<fpage>D865</fpage>–<lpage>D876</lpage>.<pub-id pub-id-type="pmid">27899602</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hamosh</surname><given-names>A.</given-names></string-name>, <string-name><surname>Scott</surname><given-names>A.F.</given-names></string-name>, <string-name><surname>Amberger</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Bocchini</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>McKusick</surname><given-names>V.A.</given-names></string-name></person-group><article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders</article-title>. <source>Nucleic Acids Res.</source><year>2005</year>; <volume>33</volume>:<fpage>D514</fpage>–<lpage>D517</lpage>.<pub-id pub-id-type="pmid">15608251</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karczewski</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Francioli</surname><given-names>L.C.</given-names></string-name>, <string-name><surname>Tiao</surname><given-names>G.</given-names></string-name>, <string-name><surname>Cummings</surname><given-names>B.B.</given-names></string-name>, <string-name><surname>Alföldi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Laricchia</surname><given-names>K.M.</given-names></string-name>, <string-name><surname>Ganna</surname><given-names>A.</given-names></string-name>, <string-name><surname>Birnbaum</surname><given-names>D.P.</given-names></string-name>, <string-name><surname>Gauthier</surname><given-names>L.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The mutational constraint spectrum quantified from variation in 141, 456 humans</article-title>. <source>Nature</source>. <year>2020</year>; <volume>581</volume>:<fpage>434</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hertzberg</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mundlos</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vingron</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gallone</surname><given-names>G.</given-names></string-name></person-group><article-title>TADA—a machine learning tool for functional annotation-based prioritisation of pathogenic CNVs</article-title>. <source>Genome Biol.</source><year>2022</year>; <volume>23</volume>:<fpage>67</fpage>.<pub-id pub-id-type="pmid">35232478</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gurbich</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Ilinsky</surname><given-names>V.V.</given-names></string-name></person-group><article-title>ClassifyCNV: a tool for clinical annotation of copy-number variants</article-title>. <source>Sci. Rep.</source><year>2020</year>; <volume>10</volume>:<fpage>20375</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">33230148</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Riggs</surname><given-names>E.R.</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>E.F.</given-names></string-name>, <string-name><surname>Cherry</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Kantarci</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kearney</surname><given-names>H.</given-names></string-name>, <string-name><surname>Patel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Raca</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ritter</surname><given-names>D.I.</given-names></string-name>, <string-name><surname>South</surname><given-names>S.T.</given-names></string-name>, <string-name name-style="given-only"><given-names>Thorland</given-names></string-name><etal>et al</etal>.</person-group><article-title>Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)</article-title>. <source>Genet. Med.</source><year>2020</year>; <volume>22</volume>:<fpage>245</fpage>–<lpage>257</lpage>.<pub-id pub-id-type="pmid">31690835</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>D’haene</surname><given-names>E.</given-names></string-name>, <string-name><surname>Vergult</surname><given-names>S.</given-names></string-name></person-group><article-title>Interpreting the impact of noncoding structural variation in neurodevelopmental disorders</article-title>. <source>Genet. Med.</source><year>2021</year>; <volume>23</volume>:<fpage>34</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">32973355</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramírez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Bhardwaj</surname><given-names>V.</given-names></string-name>, <string-name><surname>Arrigoni</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lam</surname><given-names>K.C.</given-names></string-name>, <string-name><surname>Grüning</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Villaveces</surname><given-names>J.</given-names></string-name>, <string-name><surname>Habermann</surname><given-names>B.</given-names></string-name>, <string-name><surname>Akhtar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Manke</surname><given-names>T.</given-names></string-name></person-group><article-title>High-resolution TADs reveal DNA sequences underlying genome organization in flies</article-title>. <source>Nat. Commun.</source><year>2018</year>; <volume>9</volume>:<fpage>189</fpage>.<pub-id pub-id-type="pmid">29335486</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mehrjouy</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Fonseca</surname><given-names>A.C.S.</given-names></string-name>, <string-name><surname>Ehmke</surname><given-names>N.</given-names></string-name>, <string-name><surname>Paskulin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Novelli</surname><given-names>A.</given-names></string-name>, <string-name><surname>Benedicenti</surname><given-names>F.</given-names></string-name>, <string-name><surname>Mencarelli</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Renieri</surname><given-names>A.</given-names></string-name>, <string-name><surname>Busa</surname><given-names>T.</given-names></string-name>, <string-name><surname>Missirian</surname><given-names>C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Regulatory variants of FOXG1 in the context of its topological domain organisation</article-title>. <source>Eur. J. Hum. Genet.</source><year>2018</year>; <volume>26</volume>:<fpage>186</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">29289958</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ibn-Salem</surname><given-names>J.</given-names></string-name>, <string-name><surname>Köhler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Love</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Chung</surname><given-names>H.-R.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hurles</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Haendel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Washington</surname><given-names>N.L.</given-names></string-name>, <string-name><surname>Smedley</surname><given-names>D.</given-names></string-name>, <string-name><surname>Mungall</surname><given-names>C.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Deletions of chromosomal regulatory boundaries are associated with congenital disease</article-title>. <source>Genome Biol.</source><year>2014</year>; <volume>15</volume>:<fpage>423</fpage>.<pub-id pub-id-type="pmid">25315429</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname><given-names>K.K.</given-names></string-name>, <string-name><surname>Reiss</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Crow</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ferguson</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fritzsch</surname><given-names>B.</given-names></string-name>, <string-name><surname>Morton</surname><given-names>C.C.</given-names></string-name></person-group><article-title>Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv (7)(q21. 3q35)</article-title>. <source>Hum. Genet.</source><year>2010</year>; <volume>127</volume>:<fpage>19</fpage>.<pub-id pub-id-type="pmid">19707792</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poliak</surname><given-names>S.</given-names></string-name>, <string-name><surname>Salomon</surname><given-names>D.</given-names></string-name>, <string-name><surname>Elhanany</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sabanay</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kiernan</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pevny</surname><given-names>L.</given-names></string-name>, <string-name><surname>Stewart</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>S.-Y.</given-names></string-name>, <string-name><surname>Shrager</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1</article-title>. <source>J. Cell Biol.</source><year>2003</year>; <volume>162</volume>:<fpage>1149</fpage>–<lpage>1160</lpage>.<pub-id pub-id-type="pmid">12963709</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Merlo</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Paleari</surname><given-names>L.</given-names></string-name>, <string-name><surname>Mantero</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zerega</surname><given-names>B.</given-names></string-name>, <string-name><surname>Adamska</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rinkwitz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bober</surname><given-names>E.</given-names></string-name>, <string-name><surname>Levi</surname><given-names>G.</given-names></string-name></person-group><article-title>The Dlx5 homeobox gene is essential for vestibular morphogenesis in the mouse embryo through a BMP4-mediated pathway</article-title>. <source>Dev. Biol.</source><year>2002</year>; <volume>248</volume>:<fpage>157</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">12142028</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Acampora</surname><given-names>D.</given-names></string-name>, <string-name><surname>Merlo</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Paleari</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zerega</surname><given-names>B.</given-names></string-name>, <string-name><surname>Postiglione</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Mantero</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bober</surname><given-names>E.</given-names></string-name>, <string-name><surname>Barbieri</surname><given-names>O.</given-names></string-name>, <string-name><surname>Simeone</surname><given-names>A.</given-names></string-name>, <string-name><surname>Levi</surname><given-names>G.</given-names></string-name></person-group><article-title>Craniofacial, vestibular and bone defects in mice lacking the distal-less-related gene Dlx5</article-title>. <source>Development</source>. <year>1999</year>; <volume>126</volume>:<fpage>3795</fpage>–<lpage>3809</lpage>.<pub-id pub-id-type="pmid">10433909</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Merlo</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Paleari</surname><given-names>L.</given-names></string-name>, <string-name><surname>Mantero</surname><given-names>S.</given-names></string-name>, <string-name><surname>Genova</surname><given-names>F.</given-names></string-name>, <string-name><surname>Beverdam</surname><given-names>A.</given-names></string-name>, <string-name><surname>Palmisano</surname><given-names>G.L.</given-names></string-name>, <string-name><surname>Barbieri</surname><given-names>O.</given-names></string-name>, <string-name><surname>Levi</surname><given-names>G.</given-names></string-name></person-group><article-title>Mouse model of split hand/foot malformation type I</article-title>. <source>Genesis</source>. <year>2002</year>; <volume>33</volume>:<fpage>97</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">12112878</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fudenberg</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kelley</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>K.S.</given-names></string-name></person-group><article-title>Predicting 3D genome folding from DNA sequence with Akita</article-title>. <source>Nat. Methods</source>. <year>2020</year>; <volume>17</volume>:<fpage>1111</fpage>–<lpage>1117</lpage>.<pub-id pub-id-type="pmid">33046897</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
